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animal research, it has been difficult to assess the extent to which 
experimental procedures were refined in practice. 
Structured literature reviews of research that involved the use 
of laboratory animals have provided some insights. Animal re-
search involving surgical procedures carried out on pigs, sheep, 
dogs, and non-human primates (Coulter et al., 2009), rabbits 
(Coulter et al., 2011) and rodents (Coulter et al., 2009; Richard-
son and Flecknell, 2005), published in peer-reviewed journals, 
has been analyzed with regard to analgesic and anesthetic ad-
ministration. Stokes and colleagues (2009) focused on studies 
conducted during two time periods (2000-2001 and 2005-2006) 
to assess changes in the administration of analgesics and an-
esthetics to laboratory mice and rats undergoing surgical pro-
cedures. The study showed a trend towards improvement such 
as safer anesthetic regimens used in the later period examined, 
but this and an earlier review assessing analgesic use in rodents 
(Richardson and Flecknell, 2005) found that there was still sig-
nificant scope for refinement, especially with respect to periop-
erative care. Richardson and Flecknell (2005) not only screened 
1  Introduction
Refinement, the last R of the Three Rs principles (replacement, re-
duction, refinement), was first described by Russell and Burch 60 
years ago (Russell and Burch, 1959), and pertains to “[m]ethods 
that minimize any pain, suffering, distress or lasting harm that 
may be experienced by the animals, and improve animal wel-
fare. Refinement applies to all aspects of animal use, from the 
housing and husbandry to the scientific procedures performed 
upon them” (Graham and Prescott, 2015). The revised Directive, 
2010/63/EU, requires European Union (EU) Member States to 
fully implement the Three Rs principles in their national laws 
(EU, 2010). Most states amended their national legislation in 
2013. Well before that, following the revision of the German 
Animal Welfare Act in 1972, research workers using animals 
in Germany were required to reduce any possible pain suffer-
ing, distress, or lasting harm caused to animals to an absolute 
minimum (Germany, 1972). Nevertheless, due to limitations in 
the transparency of the authorization processes and reporting of 
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Pain has a profound effect on an animal’s wellbeing. In Germany, researchers using animals have been legally required 
to reduce any possible pain, suffering, distress or lasting harm to an absolute minimum since 1972. To evaluate how 
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ARRIVE guidelines and the Gold Standard Publication Checklist (GSPC) should become legally binding. 
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refinements before Directive 2010/63/EU came into effect and 
to make recommendations about where further improvements 
could be made. To our knowledge, this is the first assessment of 
its kind. In this paper, we focus on proposed anesthetic and peri- 
and postoperative analgesic regimens and discuss deficiencies 
and necessary improvements. 
2  Materials and methods
In Germany, reviewing and licensing animal research proposals 
falls under the authority of each of the federal states. The 16 fed-
eral states have their own “competent authorities” for this task, 
generally comprised of state veterinarians. After negotiations with 
the highest authorities of the federal states, 14 of the 16 agreed 
to provide us access to original proposals for basic and applied 
research that had been granted a license. For the scope of our 
study, we selected all applications submitted to the participating 
competent authorities in 2010 that included recovery surgical 
procedures in mice and rats to assess appropriateness of anes-
thesia, perioperative analgesia, and postoperative care. Mice and 
rats are the two most commonly used species in Germany; over 
2,000,000 mice and around 400,000 rats per year are used for 
scientific purposes in Germany (BMEL, 2014, 2017). Elsewhere 
in Europe, these rodents are also among the most frequently used 
species (EC, 2013; Home Office, 2017). A total of 506 applica-
tions met these criteria and were included in the analysis. These 
included 684 recovery surgical procedures (422 in mice and 
262 in rats). The study was conducted anonymously (i.e., the 
individual research groups were not identified in the analysis).
Research proposals were included in this study if they met the 
following criteria:
1. Animal research proposal submitted to a German competent 
authority in 2010
2. Basic or applied research study
3. Species: mouse or rat
4. Procedure: surgical, recovery 
5. Original proposal that was granted a project license 
Research proposals were excluded from this study if they met 
the following criteria:
1. Application for the generation of genetically altered mice
2. Government-required animal testing, e.g., toxicity testing of 
drugs, vaccines, pesticides
3. Species other than mouse and rat
4. Procedure that did not involve recovery surgery
5. Proposal pre-assessed or rejected by members of the compe-
tent authority
We analyzed the experimental protocols described in the original 
applications. However, before approval of a final license, it is 
possible, and in some cases very likely, that the competent au-
thorities requested changes to the proposed protocols. To follow 
up on the results of the competent authorities’ assessments and 
on the amendments made in the process was not feasible. Also, 
the scope of our study was to evaluate the researchers’ awareness 
of and expertise in the application of refinement methods, not 
that of the competent authorities. 
the publications for postoperative analgesia but also e-mailed the 
authors or the respective Animal Ethics Committees a survey to 
find out when analgesia was administered independent of wheth-
er it was reported. The response rate was low (28 out of 101 
papers) and only 18% of correspondents had given analgesics 
but not reported it. A systematic review of anesthesia, analgesia, 
and euthanasia methods used in anesthesiology, respiratory, and 
critical care research published in the ten highest ranked journals 
showed insufficient reporting of treatment regimens in experi-
mental studies using small laboratory mammals; for example, 
the administration of analgesics was only reported in 19% of all 
painful interventions (Uhlig et al., 2015). 
An assessment of papers published before 2011 and from 
2014 to 2015 further confirmed that reporting of experimental 
refinement methods is still poor (Carbone and Austin, 2016). 
Whilst guidance documents specially written for reporting of 
animal studies, e.g., the Gold Standard Publication Checklist 
(GSPC) (Hooijmans et al., 2010) and the ARRIVE guidelines 
(Kilkenny et al., 2010), have been available since 2010, scien-
tific publications still cannot be relied upon to present a detailed 
description of analgesia and anesthesia protocols. Most recently, 
an assessment of anesthetic and analgesic regimens in publi-
cations on studies involving non-human primates once again 
confirmed the lack of reporting of critical detail (Bertrand et al., 
2018). Although many journals have adopted guidelines such as 
“ARRIVE”, publications continue to omit key details of study 
design and conduct (e.g., Leung et al., 2018). This may be due to 
a lack of appreciation by researchers of the need to include these 
data in their publications. It therefore remains unclear to what 
extent the experimenters did not report their refinement practices 
although, for example, proper pain management may have been 
provided. 
Besides the lack of information regarding refinement in the 
available publications, there is a general lack of transparency 
within animal research, as in all European Union Member States 
access to animal research proposals is generally restricted to 
members of the regulatory authorities. Thus, the degree to which 
refinement methods are applied in practice and the awareness of 
refinement options by research workers remains uncertain. 
German animal research proposals must include detailed de-
scriptions on how all procedures and interventions are to be con-
ducted, including precise descriptions of surgeries and the applica-
tion of refinements. The most humane and refined methods have to 
be used while still ensuring valid data collection; this is facilitated 
by a robust and effective harm-benefit analysis. For example, if 
less humane anesthetics are to be used or analgesia is withheld, 
this must be scientifically justified, and the hoped-for benefits of 
the research must outweigh also the additional harm. 
To evaluate the use of experimental refinements in German 
laboratories, we retrospectively reviewed original animal re-
search applications submitted to the German regulatory author-
ities for approval in 2010. The efficacy of the proposed anes-
thetic and peri- and postoperative analgesic regimens, the health 
monitoring, use of humane endpoints, killing methods, and the 
researchers’ categorization of the severity of planned procedures 
were investigated. The goal was to assess the application of 
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The most frequently performed surgical procedures on mice 
and rats were laparotomies. For rats, these were followed by cra-
niotomies. For mice, the second most common procedure was 
surgery that did not involve the opening of a body cavity (Fig. 1); 
examples include neuropathic pain models such as compres-
sion or ligation of nerves (e.g., ischiatic nerve), implantation 
of catheters in veins and arteries (e.g., femoral artery or vein, 
jugular vein), a hindlimb ischemia model (ligation of the femo-
ral artery), and a focal cerebral ischemia model (middle cerebral 
artery occlusion). 
Endotracheal intubation was planned for 15% of surgeries in 
mice, the vast majority of these (82%) for thoracotomies, and for 
8% of surgeries on rats, over half of these being for thoracotomies. 
3.2  Anesthetic regimens and agents used
Injectable anesthetics were the most commonly used anesthetics 
in procedures on both mice (55%) and rats (48%), followed by 
inhalant agents (mice, 36%; rats, 38%) (Fig. 2). A combination 
3  Results
Some applications lacked required information. For example, in a 
few cases the type, the dose, or the route of administration of an 
anesthetic agent was missing; the justification as to why anal-
gesia was withheld was mostly absent and there was generally 
no discussion on why certain anesthetic regimes were selected, 
even when they did not meet the standards of good veterinary 
practice. Project licenses were generally granted for up to three 
years, with the option to extend up to five years.
3.1  Types of surgical interventions and 
frequency of endotracheal intubations
The 506 assessed applications comprised 684 surgical proce-
dures. Some animals underwent more than one surgery or in some 
cases several experimental groups underwent different surgi-
cal procedures. Out of the 684 surgical procedures, 422 were 
performed on mice and 262 on rats. 
Fig. 1: Types and numbers of surgical 
procedures performed on mice and 
rats
A total of 684 surgical procedures  
were performed, 422 on mice and  
262 on rats. “Other” refers to a general 
category of all surgeries that did not 
involve the opening of a body cavity, 
e.g., compression or ligation of nerves, 
or surgery to cause a middle cerebral 
artery occlusion.
Fig. 2: Anesthetic regimens used
A total of 684 anesthetic regimens were 
performed, 422 on mice and 262 on 
rats.
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Combination of inhalational and injectable agents producing  
anesthesia
The combination of inhalational agents with injectable anes-
thetics or sedatives was used in 9% of surgeries on mice and 
13% of surgeries on rats. Here the most frequently administered 
injectable agents – ketamine and xylazine – were combined with 
isoflurane: 39% for mice; 56% for rats. The next most common-
ly used combination of anesthetics for mice was isoflurane and 
ketamine/midazolam and for rats isoflurane/nitrous oxide with 
ketamine/xylazine. In the majority (61%) of cases anesthetic 
induction was performed with the injectable anesthetic/sedative, 
followed by the use of inhalational agents. In some cases, ether 
(3% of cases) or carbon dioxide (6% of cases) was used to ini-
tiate anesthesia in rats. Carbon dioxide was however frequently 
used to kill animals (Herrmann and Flecknell, 2018a).
3.3  Perioperative analgesia 
The most frequently used perioperative analgesic agent for both 
mice and rats was buprenorphine (mice: 38%; rats: 31%), fol-
lowed by carprofen (mice: 29%; rats 27%), and fentanyl (mice: 
12%; rats: 7%) (Fig. 3). Local anesthetics such as lidocaine, 
xylocaine, ropivacaine, bupivacaine, and amethocaine were used 
in 10-13% of procedures. For instance, 22% of the craniotomies 
and 10% of the thoracotomies involved the application of local 
anesthetics at the surgical site. Metamizole was used in 8-9% of 
cases, followed by other analgesics such as paracetamol, flunixin 
meglumine, and butorphanol. Tramadol was used rarely in mice, 
but was administered after 8% of surgeries on rats. Meloxicam 
was a seldom administered agent in both species (Fig. 3).
When inhalational anesthetics with no or minimal analge-
sic properties were used, it was assessed whether and when 
they were combined with analgesics. In the case of isoflurane, 
25% of mice and 28% of rats received no pain relief, and 
13% of mice and 18% of rats received pain relief at the end of 
surgery, while the others received pain relief pre- or intraoper-
atively (Fig. 4). 
of injectable and inhalational agents was used in about 10% of 
surgeries (Fig. 2). The authors did not provide information on 
anesthesia in 1% of surgeries. For another 1% of the surgical in-
terventions it was not planned to use an anesthetic agent. Instead, 
the investigators intended to use hypothermia (cooling the an-
imals to 1-4°C by laying them on ice for about six minutes) to 
immobilize neonatal mice and rats while carrying out intracrani-
al injections of virions or neuroblasts. 
Injectable agents used for anesthesia
Ketamine and xylazine were the most frequently used inject-
ables in mice (79%) and in rats (70%). A completely revers-
ible anesthetic regimen, a mixture of fentanyl, medetomi-
dine, and midazolam, was used in 11% of mice and in 5% of 
rats. Choral hydrate was frequently used in rats (6%) but was 
rarely administered to mice (< 1% of procedures). Ketamine 
and medetomidine were also frequently used in rats (6%) rather 
than in mice (2%). Pentobarbital use ranked between 3% in mice 
and 5% in rats. Other single agents used in mice were me-
detomidine (1%) and ketamine (< 1%). Acepromazine was 
combined with xylazine and ketamine for rats (5%). In mice, 
acepromazine was combined with ketamine but this was used 
rarely (< 1%). The mixture of fentanyl, fluanisone, and midaz-
olam was also used rarely for mouse and rat surgeries (2%). In 
a few cases it was stated that reversible anesthetic agents would 
be antagonized at the end of the procedure.  
Inhalational agents 
Isoflurane was by far the most widely used inhalation agent 
(74% and 70% of procedures performed in mice and rats, respec-
tively), followed by the combination of isoflurane and nitrous 
oxide in both species (15%). For surgeries on mice, nitrous oxide 
was also used in combination with halothane (9%) as well as 
halothane alone (1%), whereas for rat surgical interventions no 
halothane use was reported, but sevoflurane (8%) and methoxy-
flurane (7%) were used.
Fig. 3: Percentage of 
analgesia agents  
and local anesthetics  
given perioperatively  
to mice and rats
Lidocaine, xylocaine, 
ropivacaine, bupivacaine, 
and amethocaine were 
used as local anesthetics. 
“Other” agents used included 
paracetamol (acetaminophen), 
flunixin meglumine, and 
butorphanol.
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The surgical procedures for which multimodal analgesia was 
provided postoperatively are listed in Table 1 (for mice) and 2 (for 
rats). In one of the two mouse procedures, the multimodal ap-
proach was optional, depending on pain being detected. The first 
three postsurgical regimens in Table 2 are identical and were used 
after various surgical procedures all described in the same research 
application. One of the aortic banding surgeries, a commonly used 
experimental model for pressure overload-induced cardiac hyper-
trophy and heart failure, used the multimodal approach only in 
case the animals did not drink enough, because metamizole was 
supplied via the drinking water, and/or the animals showed signs 
of pain. The applications involving aortic banding (Tab. 2) rep-
resent two of very few that mentioned they would monitor water 
intake. One application also stated the amount that the rats were 
expected to drink from 8 weeks old (8-12 ml/kg body weight).
No postoperative analgesia was intended following 32% of 
surgeries on mice and 30% of surgeries on rats (Fig. 5). Reasons 
for withholding analgesia were given for 24% of these surgeries 
on mice and 33% of these surgeries on rats. The most frequent 
explanations were that it was not considered necessary as pain 
was anticipated to be minor, and that the analgesic agent could 
influence study outcomes. In 11% of surgical procedures on mice 
and in 8% of surgical procedures on rats the investigators declared 
that they would administer analgesia only “if needed” (Fig. 5). 
Pain management would be considered “when signs of pain and/
or suffering were observed” or “in case of signs of moderate 
pain”. Some stated that, according to their experience, analgesia 
was not necessary for the planned surgical interventions and that 
the surgery was “tolerated well by the animals”. Overall, these 
applications contained no description of how a structured pain 
assessment would be conducted. The general health score sheets 
15% of surgical procedures had included focused on various 
health indicators, including humane endpoints, most of which are 
not specific for pain (Herrmann and Flecknell, 2018a,b). 
Similar to intraoperative pain management for mice and rats, 
buprenorphine (mice: 33%; rats: 34%) and carprofen (both: 33%) 
For injectable agents with no specific analgesic activity such 
as pentobarbital or chloral hydrate we reviewed whether these 
were combined with analgesics: With pentobarbital, analgesia 
was not provided in 55% of surgical procedures on mice and in 
75% of surgical procedures on rats. Chloral hydrate, an inject-
able anesthetic that was most frequently used for craniotomies in 
rats, was most often combined with tramadol given intraopera-
tively and, less often, with a local anesthetic.
3.4  Postoperative analgesia 
Postoperative analgesia was administered following 57% of the 
surgical interventions on mice, less than 1% being multimodal, and 
62% of procedures on rats. In only 1% and less than 2% of cases, 
respectively, were these multimodal analgesic regimens (Fig. 5). 
Fig. 4: Time of analgesic 
administration when 
isoflurane was used
Of all inhalational anesthetic 
regimens, isoflurane was used 
in 74% and 70% of surgical 
interventions in mice and rats, 
respectively.
Fig. 5: Decision on administration of analgesic treatment 
following surgical interventions
(422 on mice and 262 on rats): yes, no, and “if needed” according 
to the judgement of the researcher. 
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their drinking water. In one proposal, administration of tramadol 
via the drinking water was started preoperatively. A small number 
of investigators stated that they would switch to another analgesic 
agent or give an additional analgesic if pain was not controlled 
effectively. Some asserted that they would provide analgesia until 
no more pain was observed. However, information in regard to 
performing a structured pain assessment was absent. 
3.5  Health and pain monitoring
Health score sheets were available for 108 out of 684 surgical pro-
cedures (15%); their quality varied. The vast majority monitored 
general indicators of deteriorating health not specific to pain – such 
as weight loss, alterations in body temperature, and tumor size. 
When declaring that the animal’s behavior and overall health con-
dition would be monitored, it was mostly unclear to what extent 
this would be done and what would be done to alleviate clinical 
signs (analgesia, special bedding or other measures of intensive 
care). The planned frequency of monitoring of the animals was 
mentioned for 33% of all surgical interventions, and in the major-
ity of cases these checks were to be done once a day. More results 
on health monitoring, severity of procedures, and assessment out-
comes with regard to humane study endpoints and killing methods 
are published elsewhere (Herrmann and Flecknell, 2018a,b). 
4  Discussion
We found shortcomings in all areas we assessed. First and 
foremost, pain was often not alleviated or was unlikely to be 
alleviated effectively. Following 30% of surgical interventions, 
no analgesia was planned, and in another 10% of procedures it 
would be alleviated only if pain was observed but monitoring 
generally seemed to be infrequent or lacking. Reasons for with-
holding analgesia, if included, may indicate not only a general 
lack of monitoring, a lack of pain assessment, and a lack of pain 
recognition skills; they also imply that concerns about the neg-
were most commonly utilized to manage postoperative pain, fol-
lowed by metamizole (mice: 20%; rats: 13%) (Fig. 6). Tramadol 
was used postoperatively in 10% of surgeries in rats and in 3% 
of surgeries in mice. Meloxicam was more popular after inter-
ventions in mice (4%) than in rats (2%). Other rarely used agents 
were paracetamol, acetylsalicylic acid, flunixin meglumine, and 
local anesthetics (Fig. 6). 
Information regarding duration and frequency of postopera-
tive analgesic application was incomplete. When indicated, bu-
prenorphine was often given subcutaneously (s.c.) between once 
and three times a day for one to three days and longer, but some 
administered buprenorphine intraperitoneally (i.p.) or intramus-
cularly (i.m.). Carprofen was given mostly s.c., but at times i.p., 
i.m., orally, or via the drinking water. When not given via the 
drinking water, it was administered once or twice daily for one 
to three days, or occasionally longer. Metamizole, paracetamol, 
tramadol, and acetylsalicylic acid were usually given via the 
drinking water. Duration of administration of metamizole varied 
between one to five days, in some cases up to seven days and 
longer. Paracetamol was given mostly for two to three days. For 
tramadol, the duration was rarely mentioned and for acetylsalicyl-
ic acid not at all. The route of administration of local anesthetics 
was mostly not specified. 
Analgesic doses given were usually within the standard pub-
lished ranges with the occasional low, e.g., 2.5 mg/kg carprofen 
in rats, or high, e.g., 30 mg/kg of carprofen in mice. Meloxicam 
was dosed mostly at 0.2 mg/kg. Dosages for metamizole supplied 
via the drinking water ranged between 1.3 mg/ml and 2.5 mg/ml. 
Other doses noted were 110 mg/kg, 200 mg/kg, and 300 mg/kg. 
Paracetamol was provided at 1-3 mg/ml drinking water. Tramadol 
drinking water doses were 30 to 50 mg/kg/8h or 25 mg/l up to 200 
mg/l drinking water. It was rarely reported whether the drinking 
water intake would be measured, and how much an animal, based 
on body weight, was expected to drink to assure sufficient drug 
levels. A few investigators stated that they would administer the 
analgesic s.c. if animals showed pain despite having the agent in 
Fig. 6: Postoperative 
analgesic agents used
No analgesia was provided 
after 32% of mouse surgeries 
and after 30% of rat surgeries. 
Proposed local anesthetics 
were lidocaine, xylocaine and 
bupivacaine. Other analgesics 
included piritramide, fentanyl, 
ketamine and ketoprofen.
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finements would both significantly improve animal welfare and 
improve the quality of data obtained. 
4.1  Unalleviated pain 
As we found that pain management during and after surgery was 
often absent or inadequate, we commence the discussion with 
general considerations on the effects of unalleviated pain. Re-
searchers often appear to be concerned that (side)effects produced 
by analgesics (and anesthetics) could potentially influence or even 
confound study outcomes and data (as also seen in our study sam-
ple). However, there is an abundance of information on the phar-
macodynamics, pharmacokinetics, unwanted effects, toxicity, and 
interactions of analgesics and anesthetics with other drugs (e.g., 
Flecknell, 2016; Gaynor and Muir, 2014; Grimm et al., 2015; Muir 
and Hubbell, 2014; Informationssystem CliniPharm CliniTox1) to 
ative effects of analgesics on study outcomes were greater than 
the concerns about untreated pain. 
Considering the severity of planned surgical interventions, it 
was unexpected that use of multimodal analgesia was almost 
non-existent. Furthermore, preventive analgesia was often not 
provided as, for example, anesthetics that have no analgesic prop-
erties (e.g., isoflurane) were to be used; this was the case in a 
quarter of these procedures, and in another 13-18%, analgesia was 
planned to be given too late, and thus, the animals would recover 
consciousness without pain relief. Moreover, the use of local an-
esthetics for severe surgeries such as thoracotomies was very low 
(10% of thoracotomies). 
In the following, we discuss the problems we identified in detail 
and provide some information as to how these could be improved 
or resolved. We are confident that implementation of these re-
Tab. 1: Post-procedural multimodal analgesic approaches following surgery on mice 
Postoperative analgesia was administered following 57% of the surgical interventions on mice, less than 1% being multimodal. 






Craniotomy; chronic cranial window 
preparation (bone flap removal and 
replacement by glass cover)
Induction: isoflurane 1.5-3 Vol%;  
maintenance: isoflurane 0.8-1 Vol%; 
nitrous oxide 60%; O2 40%; intubation; 
intercostal space infiltration with ropivacaine; 
buprenorphine, 0.1 mg/kg i.p.; carprofen,  
5 mg/kg s.c.
Ketamine, 130 mg/kg and xylazine,  
10 mg/kg i.p.; carprofen, 5 mg/kg s.c., 
buprenorphine, 0.05 mg/kg i.p.
Buprenorphine, 0.1 mg/kg i.p., 3x/d, 
duration: 5 d; carprofen, 5 mg/kg s.c., 
1x/d, duration: 10 d 
 
 
Carprofen, 5 mg/kg s.c.; duration: 3 d;  
if pain detected: buprenorphine,  
0.05 mg/kg i.p. 
Tab. 2: Post-procedural multimodal analgesic approaches following surgical interventions on rats 
Postoperative analgesia was administered following 62% of procedures on rats, 2% being multimodal.
Type of surgical intervention Intraoperative regimen Multimodal regimen
Laparotomy; clamping of Ligamentum 
hepatoduodenale (Pringle maneuver); 
ischemia for 30 minutes
Laparotomy; 2/3-hepatoectomy  
(in some groups combined with  
30 minute-Pringle maneuver)
Laparotomy; placing of gastrointestinal 
tube




Partial sternotomy; aortic banding 
 
 
Placement of titanium implant on two 
critical size defects (5 mm diameter)  
per scull
Buprenorphine, 0.05-0.1 mg/kg s.c.;  
isoflurane: induction, 4-5 Vol%;  
maintenance, 1.5-3 Vol%
Buprenorphine, 0.05-0.1 mg/kg s.c.;  
isoflurane: induction, 4-5 Vol%;  
maintenance, 1.5-3 Vol%
Ketamine, 40-50 mg/kg and xylazine,  
1-2 mg/kg i.p.
Ketamine, 80-100 mg/kg and xylazine,  
1.5-5 mg/kg i.p.; injection of carprofen*  
at the beginning (route not further specified); 
intubation; injection of metamizole* at end  
of procedure (route not further specified)
Ketamine, 80-100 mg/kg and xylazine,  
1.5-5 mg/kg i.p.; intubation; metamizole*  
s.c. at end of procedure 
Ketamine, 90 mg/kg and xylazine, 10 mg/kg i.p.
Carprofen, 5-10 mg/kg s.c. 1x/d; 
buprenorphine* s.c. 2x/d, duration: 3 d 
Carprofen, 5-10 mg/kg s.c. 1x/d; 
buprenorphine* s.c. 2x/d, duration: 3 d 
Carprofen, 5-10 mg/kg s.c. 1x/d; 
buprenorphine* s.c. 2x/d, duration: 3 d
Metamizole* via drinking water for 3 d; 
carprofen* s.c. 1 d (longer if needed) 
 
 
Metamizole, 0.05 g in 50 ml drinking 
water mixed with 0.25 ml 20% glucose 
solution for 3 d; if needed additionally 
carprofen* s.c. 1x/d
Carprofen, 5 mg/kg 2x/d; buprenorphine, 
0.05-0.1 mg/kg 2x/d, both s.c.; duration:  
1 d, max. 2 d
*no dose given
1 CliniPharm Wirkstoffdaten. http://www.vetpharm.uzh.ch/perldocs/index_i.htm
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in small rodents but it is relatively easy to perform with the cor-
rect apparatus (Flecknell, 2016).
Hypothermia
For experiments where neonatal mice and rats were to be injected 
intracranially, the researchers planned to use hypothermia to immo-
bilize them. The investigators would then inject the animals’ brains 
with virions or neuroblasts. In neonatal rodents, the nociceptive 
pathways are thought to be not yet fully developed (Fitzgerald, 
2005). However, recovery from hypothermia is possibly associated 
with pain as it has been shown to lead to c-Fos activation (Rhodes, 
2009). Since there are anesthetic agents available for neonatal 
mice and rats such as methoxyflurane (Danneman and Mandrell, 
1997) or fentanyl/fluanisone (Clowry and Flecknell, 2000), the use 
of hypothermia should be abandoned. It is our understanding that 
the German competent authorities generally do not allow this con-
troversial practice (Projektgruppe der Genehmigungsbehörden, 
personal communications, 2016).
Pentobarbital
A number of surgical interventions were conducted under the 
hypnotic agent pentobarbital, given intraperitoneally. Doses 
ranged from 36 mg/kg body weight up to 60 mg/kg in mice and up 
to 70 mg/kg in rats whereas recommended doses are between 40-
50 mg/kg (Field et al., 1993). Pentobarbital has a narrow safety 
margin and is best used to provide a light plane of anesthesia 
rather than for surgical interventions, for which doses close to 
the lethal dose may be required (Flecknell, 2016). The high pH 
of pentobarbital (11) causes pain when injected intraperitone-
ally. Pentobarbital also results in prolonged sleep time in rats 
(120-240 min) and mice (120-180 min) (Flecknell, 2016), and 
during this period, animals have depressed cardiovascular and 
respiratory systems and are susceptible to hypothermia. 
Chloral hydrate
Choral hydrate was rarely used in mice, but was the second most 
frequently used agent in rats. However, it can cause adynamic 
ileus in rats (Fleischman et al., 1977) and it often produces only a 
light plane of anesthesia. Most investigators using choral hydrate 
planned to give perioperative analgesia. Nonetheless, due to the 
danger of causing adynamic ileus, chloral hydrate should be re-
placed by more effective and safer agents (Baxter et al., 2009).
Use of ketamine or medetomidine as the sole agent
There were few cases for which the use of ketamine or medeto-
midine as single agents was planned. Used alone, these agents 
cause sedation and mild to moderate analgesia, but they must be 
combined with other agents to produce surgical anesthesia. The 
combination of ketamine with acepromazine or with midazol-
am does not usually provide an anesthetic depth necessary for 
surgery in either species (Flecknell, 2016); hence, for surgical 
interventions, additional agents are needed.
Use of inappropriate inhalational agents for induction  
of anesthesia
For rats, ether was used in 3% and carbon dioxide in 6% of pro-
tocols to initiate anesthesia. Induction with both of these agents 
guide investigators when designing their studies. In addition, there 
is an increasing number of recommendations for the refinement 
of certain models and procedures, for example, for models of 
ischemic stroke (Percie du Sert et al., 2017), for rheumatoid ar-
thritis (Hawkins et al., 2015), for sepsis and septic shock (Lilley 
et al., 2015), for experimental autoimmune encephalomyelitis 
(EAE) (Wolfensohn et al., 2013a), and for procedures involving 
seizures, convulsions, and epilepsy (Lidster et al., 2016; Wolfen-
sohn et al., 2013b). These guidelines were composed by experts 
based on their knowledge of the particular models and the value 
of potential refinements. Furthermore, specialists in veterinary 
anesthesia and analgesia in a research setting can give additional, 
project-specific advice and guidance.
Unalleviated pain has profound effects on the animal, leading 
to emotional, behavioral, and physiological changes (see Jirkof, 
2017; Peterson et al., 2017). The immune system is suppressed 
due to pain stimulating glucocorticoid and catecholamine 
release. Responses to pain vary between individuals, and con-
sequently are hard to predict, which potentially makes pain a 
poorly controlled study variable. In comparison, the influence of 
anesthetic and analgesic agents on the data is more foreseeable 
than the effects of unalleviated pain, distress, and suffering on 
in vivo research. In addition, use of perioperative analgesics – if 
based on the need of the individual animal elicited by properly 
and frequently conducted structured pain assessments – will 
most likely have relatively minor effects on the animal model. 
Confounding effects are more likely to be introduced by anal-
gesics when the agents are given over an extended time period 
or in unnecessarily high dosages. The likely effects are often 
overestimated and based on studies in which analgesics were 
administered at elevated doses and for time periods longer than 
needed in most experimental settings (e.g., Hall et al., 1996). 
Furthermore, models designed to be of relevance to clinical 
conditions in humans should be treated as in the human setting, 
where pain would generally be alleviated whenever possible. A 
plan for adequate and controlled pain management should be 
developed as part of the study protocol. To sufficiently manage 
pain, the choice of anesthetics and analgesics, their dose, admin-
istration route, frequency and duration of treatment, and a pain 
assessment plan should be tailored to the individual research 
project, treatment group and, if necessary, to an individual an-
imal’s needs.
4.2  Need for refinement of anesthetic protocols
Endotracheal intubation
Intubation was performed in 8% and 15% of surgeries (rats and 
mice, respectively), and the majority of these were thoracoto-
mies. When opening the thoracic cavity, endotracheal intubation 
is generally indicated as the animals require mechanical ven-
tilation to maintain respiratory function. In addition, there are 
certain disease models where intubation and mechanical venti-
lation is of considerable benefit. For example, the lesion size in 
experimental models of stroke is influenced by cerebral blood 
flow and the degree of cerebral vasodilation. These variables are 
markedly affected by changes in arterial carbon dioxide, which 
can be maintained at a consistent level by mechanical ventilation 
(Liu et al., 2009). Tracheal intubation might appear challenging 
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sleep time. This risk can be reduced by using anesthetic agents 
that can be reversed such as medetomidine and xylazine with 
atipamezole; midazolam with flumazenil and fentanyl with bu-
torphanol, buprenorphine or naloxone. Some researchers who 
used reversible anesthetic regimens planned to antagonize these 
at the end of the procedure. This should be done routinely to 
avoid long sleep times and ensure a faster recovery. 
Most investigators in our study sample used ketamine and 
xylazine, a regimen associated with prolonged recovery periods 
(Albrecht et al., 2014). Ketamine/xylazine and ketamine/mede-
tomidine could be partially antagonized with atipamezole; this 
should be considered to reduce recovery time.
Pre-medication and balanced anesthesia
Isoflurane was the most frequent inhalational anesthetic used. There 
seems to be a general trend towards using inhalant anesthetics, 
probably because induction is rapid, anesthesia levels can be ad-
justed to the individual animal’s needs, and recovery from anes-
thesia is fast. Isoflurane undergoes almost no biotransformation; 
however, it is mildly pungent (Eger, 1981). Most commonly used 
inhalational agents are to some degree pungent to rodents, and 
studies have shown increased aversion and distress after repeated 
exposure to, e.g., isoflurane and halothane (Makowska and Weary, 
2009). Hence, it is advisable to use pre-medication such as fentan-
yl/fluanisone or midazolam/fentanyl for induction before mainte-
nance with an inhalational agent. Other commonly used pre-med-
ication agents are medetomidine, dexmedetomidine, or xylazine. 
Another advantage of using sedatives and analgesics as 
pre-anesthetic medication is that this produces a balanced an-
esthesia where the dosage of each component can be reduced, 
while inducing general anesthesia of sufficient depth with fewer 
side effects. For example, administration with midazolam and 
fentanyl has been shown to improve sevoflurane anesthesia for 
moderately painful surgeries in mice (Lipiski et al., 2017). De-
pressant effects of sevoflurane on the respiratory rate and the 
negative post-anesthetic effects on heart rate were decreased by 
use of pre-anesthetic medication. 
Hence, to avoid unnecessary animal distress as well as to 
minimize potential negative effects of anesthesia on the research 
subject, balanced anesthesia should be the norm.
4.3  Inadequate analgesia
Lack of preventive analgesia
When anesthetics with no or minimal analgesic properties were 
used, e.g., in the case of isoflurane, 25% of mice and 28% of rats 
received no pain relief, and 13% of mice and 18% of rats received 
pain relief only at the end of surgery. Anesthetic agents without 
analgesic properties such as isoflurane and sevoflurane should al-
ways be combined with analgesics to ensure sufficient pain relief 
at the time the animal regains consciousness (Flecknell, 2016; 
Miller and Richardson, 2011). Since most analgesics only reach 
full onset of action 15 to 45 minutes after administration, it is 
advisable to administer the analgesic preoperatively. Preventive 
analgesia reduces both noxious stimuli reaching the central ner-
vous system during surgery and peripheral inflammation (Miller 
and Richardson, 2011). Perioperative analgesics may also have 
an anesthetic sparing effect (Penderis and Franklin, 2005). 
is distressing and aversive due to irritation of the mucus mem-
branes. Coughing, salivation, and at times laryngospasm occur 
from inhaling ether (Flecknell, 2016). Carbon dioxide is strongly 
aversive, and causes distress and fear in rodents (e.g., Chisholm 
et al., 2013; Kirkden et al., 2008; Leach et al., 2002a,b, 2004; 
Makowska and Weary, 2009; Marquardt, 2013; Niel and Weary, 
2007; Niel et al., 2008; Wong et al., 2013; Ziemann et al., 2009) 
and thus, its use as a killing agent has been controversial for 
many years. Rats and mice are unwilling to tolerate exposure 
to CO2 long enough to lose consciousness (Leach et al., 2002b, 
2004; Niel and Weary, 2007; Niel et al., 2008). Food incentives 
to stay in the gas chamber (Leach et al., 2004; Niel and Weary, 
2007) and withholding food for up to 24 hours to increase their 
motivation to stay in the chamber longer as well as varying the 
gas flow rates did not change the time they were willing to toler-
ate carbon dioxide (Niel et al., 2008). When comparing carbon 
dioxide to other anesthetic gases, it was found to be the most 
aversive gas for both mice and rats, with the least aversive being 
enflurane and halothane for mice and halothane for rats (Leach 
et al., 2002a). Other studies compared rats’ aversion to carbon 
dioxide with isoflurane or halothane exposure and concluded 
that the fluorinated hydrocarbons were less aversive than car-
bon dioxide (Kirkden et al., 2008; Makowska and Weary, 2009; 
Wong et al., 2013; Young, 2006). 
Recommendations 
Dosing and route of administration
Drug doses vary between species, strains, and individuals and 
depend on age, sex, and health condition of the individual animal 
(Flecknell, 2016). Therefore, we only discuss chosen dosages if 
they were outside of the standard range. Injectable anesthetics 
were the most widely used agents in both mice and rats. They 
can provide safe and effective anesthesia, but this is most easily 
achieved when given intravenously, so that the dosage can be 
adjusted to provide the desired effect in that particular animal. 
However, this is generally not feasible for small rodents, who thus 
receive most injectable anesthetic agents intraperitoneally (i.p.) 
and less often subcutaneously (s.c.) or intramuscularly (i.m.). 
Several studies have shown that intraperitoneal applications have 
a high failure rate (6-20% for experienced personnel) with some 
of the material being injected, e.g., into the fatty tissues, viscera, 
or caecum (Ballard, 2009; Coria-Avila et al., 2007; Gaines Das 
and North, 2007; Lewis et al., 1966). Intramuscular injections 
can be painful, and in the case of ketamine, for example, they can 
produce necrosis (Smiler et al., 1990). The subcutaneous route 
seems the least invasive, however, data comparing the accuracy 
of dosing with i.p. administration is not available. Since inject-
able anesthetics are administered as a single dose, overdosing 
or underdosing can easily occur. To avoid complications, agents 
with a wide safety margin should be used as well as agents whose 
effects can be reversed using specific antagonists.
Reversible anesthetic agents
Due to their small body size, rodents are prone to hypothermia, 
and respiratory and cardiovascular depression (Fleischmann et 
al., 2016), and mortality increases with prolonged postsurgical 
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Analgesic dosing
Analgesic doses should be selected according to the anticipated 
and then actual severity of the surgical intervention, the strain and 
the animal’s individual response to the treatment (Wright-Wil-
liams et al., 2013). The general dose recommendations for car-
profen given to mice are 4-5 mg/kg (e.g., GV-SOLAS and TVT, 
2015) and for ketoprofen 2-5 mg/kg (Matsumiya et al., 2012). 
Depending on the degree of acute pain, a 2- to 4-fold higher dose 
can be needed for the analgesic to be efficient (Matsumiya et al., 
2012). However, these increased doses of NSAIDs may result in 
undesirable side effects such as gastrointestinal ulceration. 
Meloxicam, at the doses proposed, is unlikely to be effective in 
managing postoperative pain since significantly higher doses are 
required (Roughan et al., 2016; Wright-Williams et al., 2007). 
A recent re-assessment of the efficacy of meloxicam for post- 
laparotomy pain in mice suggested that it had anti-inflammatory 
activity but failed to prevent pain, even at high doses (Roughan 
et al., 2016). A slow-release formulation of meloxicam also did 
not control pain of rats after skin incision under general anesthe-
sia (Seymour et al., 2016).
Slow release formulations
Repeated handling and restraint causes distress (Balcombe et al., 
2004; Meijer et al., 2006) and can add to postsurgical pain in 
newly operated animals (Jirkof et al., 2015). Thus, the frequen-
cy of analgesic injections should be minimized. However, the 
serum concentrations for, e.g., buprenorphine (Temgesic®) indi-
cate that its duration of action in mice is less than 8 hours (Jirkof 
et al., 2015). Thus, to maintain effective serum concentrations, 
this agent should be given at approximately 6-hour intervals. 
Slow-release formulations could be administered to reduce this 
to once every 24-48 hours in mice (Jirkof et al., 2015; Kendall, 
2016) and up to once every 72 hours in rats (Foley et al., 2011; 
Chum, 2014). However, these slow-release formulations are cur-
rently only available in the USA. 
Non-provision of analgesia: reasons, responsibilities, and  
refinement
Approximately 30% of surgeries on mice and rats were not to 
be followed with any postoperative analgesia. However, pain 
occurrence is to be expected for all surgical procedures. Annex 
VIII of Directive 2010/63/EU (similar to previous guidance 
documents on severity of procedures) classifies “surgery under 
general anaesthesia and appropriate analgesia, associated with 
post-surgical pain, suffering or impairment of general condition” 
as moderate in severity and “surgical and other interventions in 
animals under general anaesthesia which are expected to result in 
severe or persistent moderate postoperative pain, suffering or dis-
tress or severe and persistent impairment of the general condition 
of the animals” as severe (EU, 2010). In contrast, almost 40% of 
the 684 surgeries included in our review were classified as mild by 
the researchers (Herrmann and Flecknell, 2018b). Explanations 
for not expecting and not detecting pain might be the overall low 
frequency of observation of the animals, the absence of structured 
pain assessments, as well as a general lack of knowledge about 
pain-related behaviors in mice and rats and the impact/severity of 
surgical interventions performed on them. 
Lack of use of local anesthetics 
Splash blocks (instillation of local anesthetics at surgery site) 
were used in 22% of craniotomies; for 10% of mice and rat 
thoracotomies local anesthetics were used for intercostal infil-
tration or as splash blocks. Incorporating local anesthetics into 
intraoperative regimens of surgeries known to cause severe pain 
is a valuable refinement. Combining lidocaine (10 mg/kg) and 
bupivacaine (5 mg/kg) provides safe and effective analgesia in a 
range of species (Flecknell, 2018).
Absence of multimodal analgesia
Multimodal analgesia, the use of different classes of analgesics, 
including local anesthetics, opioids, and nonsteroidal anti-inflam-
matory drugs (NSAIDs) in combination, represents current best 
practice. Besides this approach being the most effective in man-
aging pain, it also helps to avoid side effects caused by the use 
of high doses of a single analgesic agent (Miller and Richardson, 
2011; Flecknell, 2016). However, in the reviewed studies, multi-
modal analgesia was rarely chosen.
Intake via the drinking water
The sole application of an analgesic agent in the drinking water 
was a frequent method of analgesic administration, but effective-
ness of this approach for managing pain is highly questionable 
as it is uncertain if the individual animal consumes sufficient 
analgesic to reach effective plasma concentrations (Sauer et al., 
2016). This is especially difficult to achieve during the light 
phase of the animal’s photoperiod when mice and rats drink 
infrequently (Graf et al., 2016). An additional problem can be 
the unfamiliar taste of the medicated drinking water. To accus-
tom the animals to the water mix, provision should start a day 
or two before the surgical intervention (as planned in one of 
the reviewed proposals). A recent study demonstrated that the 
mixture of tramadol and paracetamol was voluntarily consumed 
via the drinking water in sufficient amounts to alleviate mild to 
moderate postsurgical pain (Jirkof et al., 2018). It was concluded 
that this protocol should at least partially alleviate pain, but the 
authors considered that additional analgesic agents would be re-
quired after surgical interventions that caused more severe pain. 
Analgesic delivery via the drinking water should be combined 
with another analgesic, given by injection, to provide analgesia 
during the light phase of the animal’s photoperiod when water 
intake is decreased (Sauer et al., 2016). It is also practicable to 
train animals to consume analgesics in a palatable base, and to 
dose animals individually in this way (Kalliokoski et al., 2011; 
Leach at al., 2010).
Studies on the efficacy of the oral application of metamizole, 
an agent that seems especially popular in German laboratories 
(see Fig. 3 and 6), appear lacking. Metamizole is a pyrazolone 
derivate with antipyretic and analgesic properties. Its use in 
medical practice has been prohibited in many countries since the 
1970s after its use was linked to agranulocytosis. However, it 
appears that the risk of metamizole-induced agranulocytosis was 
exaggerated (Jasiecka et al., 2014) and the agent continues to 
be available in Germany. A study to verify if it is an effective 
postoperative analgesic in rodents is urgently needed.
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is insufficient to administer an analgesic and assume that pain is 
alleviated. Observations to assess pain are more likely to be suc-
cessful when animals are familiar with the people who observe 
and handle them and provide veterinary care. This highlights the 
importance of frequent positive interactions with the animals. 
Besides gentle handling practices (Hurst and West, 2010; Gou-
veia and Hurst, 2013), successes of positive reinforcement train-
ing in mice (Leidinger, 2018) and rats (Schuppli et al., 2017) 
leading to positive animal-human relationships that could help 
with ensuring their pain is managed effectively. 
Monitoring criteria
Common behavioral alterations in mice and rats that can indicate 
pain are, e.g., decreased activity levels (Wright-Williams et al., 
2007; Karas, 2002), sleep disturbances, reduced water and food 
intake (Liles et al., 1993; Carstens and Moberg, 2000), changes 
in nest building (Deacon, 2012; Jirkof et al., 2013; Jirkof, 2014), 
burrowing (Deacon, 2006, 2009, 2012; Jirkof et al., 2010; Jirkof, 
2014), and grooming behavior (Miller et al., 2016). Specific 
behaviors associated with abdominal pain in rodents include 
pressing the abdomen against the cage floor, raising the tail 
while walking, flinching, twitching of back muscles, partial loss 
of balance when walking, and lifting one leg straight out behind 
(Wright-Williams et al., 2007; Leach et al., 2012; Miller et al., 
2012, 2016). The observation and scoring of these behaviors can 
be complemented with monitoring of burrowing and nest build-
ing behaviors as in some strains these have been shown to be 
useful not only for disease progression, but also as signs of pain 
and distress (Jirkof, 2014). A prerequisite is that baseline data is 
obtained for the particular strain. 
Another approach to pain assessment is the use of the grimace 
scale for mice (Langford et al., 2010; Leach et al., 2012) and rats 
(Sotocinal et al., 2011). The Mouse Grimace Scale (MGS) and 
Rat Grimace Scale (RGS) have been used successfully to assess 
spontaneous, postoperative pain that can be detected for 36 to 
48 hours after surgery (Matsumiya, 2012). For research purpos-
es, the MGS and RGS are used by scoring images taken from 
digital video. This system also has been used by animal care 
staff and research workers (Matsumiya, 2012), who confirmed 
user friendliness and sensitivity of the method (e.g., Faller et al., 
2015). Using multiple blinded observers, previously overlooked 
low-level pain was identified in a study where the system was 
used to assess the efficacy of postsurgical analgesia protocols 
following thoracotomy for surgical induction of myocardial in-
farction (Faller et al., 2015). Furthermore, this tool has shown 
potential in the search for effective analgesic dose ranges. The 
use of the MGS showed that currently recommended doses of 
carprofen and ketoprofen were insufficient to manage postsur-
gical pain, and that paracetamol was an inadequate agent at any 
dose (Matsumiya et al., 2012). The grimace scale should be com-
bined with monitoring other pain-related behaviors mentioned 
above, water and food intake, locomotor and exploratory activ-
ity, as well as changes in nest building and burrowing behavior 
in order to optimize pain management strategies. Structured pain 
assessments take time and therefore require sufficient numbers 
of trained personnel. However, they are central to assuring the 
efficacy of analgesic treatment.
Ensuring that the animals used in procedures experience the 
minimum of pain, distress, and suffering is one of the investi-
gator’s primary responsibilities (Germany, 1986). Research 
applications for surgical procedures not planning to provide 
postoperative pain management with no scientifically plausible 
explanation should not be approved. If withholding pain relief is 
indeed necessary from a scientific standpoint, the harm-benefit 
analysis has to demonstrate that the anticipated benefit of the 
research outweighs and thus justifies the painful experience for 
the animal. When analyzing the restrictions of research studies 
in detail, a solution/compromise can often be found. It might not 
be possible to provide the animal with the best available pain 
management, but it is almost always possible to improve the 
animal’s welfare, at least by avoiding factors that can cause and 
increase pain and distress. Appropriate intra- and postoperative 
measures also help the animals to recover more rapidly. 
Postsurgical pain is likely to be present for at least 48 hours 
after surgery, and for longer when more invasive procedures 
such as thoracotomies or orthopedic procedures are undertaken. 
Since all opioids that are currently available in the EU act for 
less than 8 hours, repeated administration will be required to 
provide effective analgesia. When used alone, particularly in 
mice, NSAIDs provide insufficient analgesia following major 
surgery. Although handling and restraint to administer addi-
tional analgesics can cause stress, prior positive reinforcement 
training of the animals and use of tunnel handling of mice can 
greatly reduce this adverse effect. In any event, the stress of 
handling is likely to be minimal in comparison to unalleviated 
post-surgical pain.
4.4  Lack of recognition and assessment of pain
For 10% of all surgical procedures, the researchers stated that 
analgesia would not be necessary, but would be provided if signs 
of pain or suffering were observed. As mentioned before, infor-
mation concerning structured pain assessment was generally ab-
sent. Our findings correlate with results from a study conducted 
in the UK where almost none of the 28 institutions in the survey 
used pain assessment methods. Although their efficacy was not 
assessed, the British laboratories routinely provided the animals 
with analgesics (Hawkins, 2002). 
In many cases, investigators stated that animals would be 
monitored “frequently” without defining what this would mean. 
When the frequency of health inspections was specified, most 
of these checks were to be done once a day. Yet, daily inspec-
tions are a minimum legal requirement for healthy animals (EC, 
2007). Even before Directive 2010/63/EU was published, recov-
ery surgical procedures were generally rated as at least moderate 
in severity (Martini et al., 2000). Thus, animals that have under-
gone surgery require much more frequent monitoring to assure 
that pain is recognized and managed effectively. 
Recommendations
Positive reinforcement training
The degree to which pain is perceived and the way the presence 
of pain is expressed by animals varies greatly between species, 
strains, sexes, age, health status, as well as among individuals. 
Therefore, proper pain assessment schemes are necessary as it 
Herrmann and Flecknell
ALTEX 36(1), 2019 76
to improve and harmonize education and training in the EU was 
produced by an Expert Working Group (National Competent 
Authorities, 2014). Incorporating the learning outcomes into 
the relevant training modules and ensuring that all new research 
workers attend formal courses to deliver this training effectively 
should improve the implementation of refinements. Refresher 
training for more experienced researchers is recommended and 
more formal requirements for this should also be considered.
It is critical that clear descriptions regarding the provision 
of adequate pain management (and all other refinements) are 
included in research proposals and in publications to avoid 
needless pain and suffering of the animals. Full disclosure in 
the proposals and in the publications is also essential to enable 
the replication of the studies and to understand the findings. 
Researchers build their work on the work of other researchers, 
mostly by using information given in publications, and regula-
tory authorities and bodies, such as animal research and ethics 
committees, Animal Welfare Bodies (AWBs), and Animal Care 
and Use Committees (ACUCs), make their decisions on the con-
tent presented in proposals. Hence, openness about all aspects 
and details is imperative. 
Finally, investigators should closely follow the PREPARE 
(Smith et al., 2017) and ARRIVE guidelines or the Gold Standard 
Publication Checklist (GSPC) to provide essential data required 
for interpretation of their results. Funding agencies and scientific 
journals still do not demand full disclosure of this information 
(Baker et al., 2014; Carbone and Austin, 2016; Enserink, 2017; 
Reichlin et al., 2016). A recent randomized controlled trial of an 
Intervention to Improve Compliance with the ARRIVE guide-
lines revealed that the request to fill in an ARRIVE checklist did 
not lead to full compliance with the guidelines in the manuscript 
(Hair et al., 2018). Thus, legal enforcement of compliance with 
preparation and reporting checklists, in addition to compre-
hensive training on all checklist items, appears critical to fulfil 
already existing legal requirements as well as responsibilities to 
the public, who ultimately funds research and, as opinion polls 
(e.g., Clemence and Leaman, 2016) show, expects that suffering 
is minimized.
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Monitoring in the nocturnal phase
Rodents are generally more active in the dark phase of their 
photoperiod (Wells, 2017), so other useful tools to employ are 
remote video-monitoring of animals in their home cage and, in 
certain settings, the use of automated cages that are able to de-
tect and record rapid changes in normal behavior (Miller et al., 
2011; Wright-Williams et al., 2013; Jourdan et al., 2001). Lim-
itations of currently available automated cages are that abnormal 
behaviors which are associated with pain such as pressing the 
abdomen on the cage floor or slow contortion of abdominal flank 
muscles are not detected. 
5  Conclusions
The findings of this first-of-its kind review of original animal 
research proposals confirms international trends detected in var-
ious previous appraisals (see also Bara and Joffe, 2014; Taylor, 
2010; Pound and Nicol, 2018; Uhlig et al., 2015). Although 
reporting of analgesia and anesthesia in scientific publications 
is often incomplete, it is highly probable that, for example, post-
operative analgesia was not provided if it is not mentioned in 
the publication. Our assessment shows that legal requirements 
to comprehensively apply available methods of refinement were 
not followed in the study sample. In particular, provision of 
pain management was often either not planned or the proposed 
regimens were not appropriate, and optimal techniques such 
as multimodal analgesia were almost never used to alleviate 
postoperative pain in laboratory rodents. Pain assessment tools 
and schemes were not utilized, and effective health monitor-
ing seemed to be lacking. To assess whether the situation has 
changed since Directive 2010/63/EU came into effect in 2013, 
it would be important for this study to be repeated, as well as 
expanded to other EU Member States. 
Since animal research workers are legally bound to reduce 
discomfort, pain, and suffering of animals to an absolute mini-
mum, a possible explanation for the deficiencies in the research 
applications is that they have not received sufficient education 
as well as adequate on-going training in refinement methods and 
animal welfare.
The number of investigators who underestimated the severity 
of their procedures (see Herrmann and Flecknell, 2018b) also 
suggests there is a knowledge gap. To ensure that animal re-
search is conducted in the most responsible and least invasive 
way, resulting in findings that are valid and reproducible, profes-
sional assistance and comprehensive training are required. It is 
important to educate researchers not only on how experiments, 
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